Bicocca Open Archive

Logo unimib boa
CAZZANIGA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.217
EU - Europa 7.711
AS - Asia 3.135
SA - Sud America 39
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 10
Totale 31.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.979
IT - Italia 1.527
IE - Irlanda 1.376
CN - Cina 1.272
SE - Svezia 1.264
DE - Germania 991
SG - Singapore 854
UA - Ucraina 693
RU - Federazione Russa 679
HK - Hong Kong 536
GB - Regno Unito 365
CA - Canada 234
FI - Finlandia 212
FR - Francia 165
VN - Vietnam 159
AT - Austria 137
TR - Turchia 96
IN - India 88
DK - Danimarca 70
NL - Olanda 58
BE - Belgio 56
ID - Indonesia 52
JP - Giappone 29
BR - Brasile 23
ES - Italia 16
EU - Europa 16
BG - Bulgaria 15
CH - Svizzera 15
GR - Grecia 13
IR - Iran 13
CZ - Repubblica Ceca 11
NO - Norvegia 11
RO - Romania 11
AR - Argentina 10
AU - Australia 9
KR - Corea 8
EG - Egitto 7
PL - Polonia 7
MU - Mauritius 6
TH - Thailandia 6
PT - Portogallo 5
CL - Cile 4
RE - Reunion 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IL - Israele 3
PH - Filippine 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
MX - Messico 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TW - Taiwan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
EE - Estonia 1
GL - Groenlandia 1
HU - Ungheria 1
LT - Lituania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
TG - Togo 1
VE - Venezuela 1
Totale 31.156
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.634
Fairfield 2.292
Woodbridge 2.114
Houston 1.638
Dublin 1.344
Chandler 1.252
Ashburn 1.104
Wilmington 1.058
Seattle 865
Cambridge 798
Jacksonville 755
Frankfurt am Main 750
Singapore 699
Dearborn 605
New York 535
Hong Kong 533
Princeton 492
Milan 381
Lawrence 239
Nanjing 227
Altamura 224
Shanghai 183
Beijing 155
Santa Clara 151
San Diego 147
Vienna 135
Lachine 124
Dong Ket 80
Andover 79
Nanchang 77
Lissone 74
Helsinki 72
Shenyang 63
Toronto 62
Fuzhou 58
Rome 57
Guangzhou 56
Hebei 55
Boardman 53
Brussels 52
Jakarta 51
Changsha 48
Jinan 48
Tianjin 46
Norwalk 41
London 38
Falls Church 34
Los Angeles 34
Jiaxing 32
Chicago 29
Ningbo 29
Zhengzhou 28
Hangzhou 26
Besana In Brianza 25
Fremont 25
Pune 25
Ottawa 24
Redmond 24
Kocaeli 23
Kunming 23
Mountain View 23
Paris 22
Dallas 20
Huizen 20
Monza 20
Göttingen 17
Hefei 17
Padova 17
San Mateo 17
Turin 17
Bologna 16
Florence 14
Edmonton 13
Grafing 13
Sesto San Giovanni 13
Taizhou 13
Carate Brianza 12
Athens 11
Brugherio 11
Cinisello Balsamo 11
Nürnberg 11
Washington 11
Hounslow 10
Perugia 10
Lappeenranta 9
Leawood 9
Mariano Comense 9
Oslo 9
Phoenix 9
Allentown 8
Auburn Hills 8
Bari 8
Moscow 8
University Park 8
Amsterdam 7
Bonndorf 7
Cassano Magnago 7
Desio 7
Mumbai 7
Munich 7
Totale 24.411
Salva come PNG Salva come JPEG
Nome #
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 336
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 310
NIPBL: a new player in myeloid cells differentiation 301
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 294
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 284
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 277
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 273
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 256
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 248
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 236
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 232
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 231
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 229
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 225
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 223
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 214
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 212
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 212
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 210
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 204
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 200
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 192
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 192
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 192
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 190
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 190
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 189
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response 188
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 187
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 186
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 185
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 184
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 183
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 183
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 183
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 181
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 179
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype 178
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 177
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group 177
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 175
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions 175
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 174
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 174
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia 174
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 170
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 169
Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts 169
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 167
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 164
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 163
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 163
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 162
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 162
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study 160
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 160
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 160
The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis 159
Rings and bricks: Expression of cohesin components is dynamic during development and adult life 159
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 159
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias 158
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations 156
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome 156
TEL/ARG induces cytoskeletal abnormalities in 293T cells 156
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 156
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol 156
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study 155
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL 155
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 154
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia 152
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 152
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 152
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 151
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 151
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 151
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 150
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 149
Predictive factors of relapse and survival in childhood acute myeloid leukemia: Role of minimal residual disease 148
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 147
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia 147
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 147
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 147
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 146
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 146
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: Revisited in AIEOP-BFM protocol 145
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 144
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 142
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia 142
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 142
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells 142
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 139
Metabolic gatekeeper function of B-lymphoid transcription factors 138
T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses 137
SSBP2-CSF1R is a Recurrent Fusion in B-lineage Acute Lymphoblastic Leukaemia with Diverse Genetic Presentation and Variable Outcome 137
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome 136
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 136
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 136
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 135
Loss of CBL E3-ligase activity in B-lineage childhood acute lymphoblastic leukaemia 134
Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster 134
Totale 17.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.058 0 0 408 607 651 776 796 450 553 343 317 157
2020/20215.491 222 341 432 474 446 436 816 678 399 494 350 403
2021/20223.278 232 342 419 237 256 271 123 177 208 230 227 556
2022/20235.119 663 1.625 374 426 282 793 67 292 332 31 154 80
2023/20244.081 119 130 173 185 528 1.087 816 152 357 85 81 368
2024/20251.774 466 1.067 241 0 0 0 0 0 0 0 0 0
Totale 32.276